Azobisisobutyronitrile → tert-Butyl 4-(bromomethyl)-1H-benzo[d]imidazole-1-carboxylate

HRID 8960

Reaktionsgleichung

Reaktionsgleichung von HRID 8960
[C:1]([O:5][C:6]([N:8]1[C:12]2[CH:13]=[CH:14][CH:15]=[C:16]([CH3:17])[C:11]=2[N:10]=[CH:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].[Br:18]N1C(=O)CCC1=O.N(C(C)(C)C#N)=NC(C)(C)C#N>C(Cl)(Cl)(Cl)Cl>[C:1]([O:5][C:6]([N:8]1[C:12]2[CH:13]=[CH:14][CH:15]=[C:16]([CH2:17][Br:18])[C:11]=2[N:10]=[CH:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2]

Komponenten

5

Versuchsvorschrift

To a stirred solution of 4-methyl-benzimidazole-1-carboxylic acid tert-butyl ester (800 mg, 3.4 mmol) in CCl4 (7 mL) was added N-bromosuccinimide (730 mg, 4.1 mmol) and 2,2′-azobis(2-methylpropionitrile) (84 mg, 0.51 mmol). The resultant mixture was heated at reflux for 18 h after which it was filtered and concentrated to a yellow/orange syrup and crystals (1.4 g). Purification by column chromatography on silica gel (200:15—Hexanes:EtOAc) gave the desired title compound as a yellow syrup (635 mg, 60%). 1H NMR (300 MHz, CDCl3) δ 8.48 (s, 1H), 7.95 (dd, 1H, J=7.8, 1.5 Hz), 7.42–7.34 (m, 2H), 4.96 (s, 2H), 1.71 (s, 9H).

Aufarbeitung

  1. temperatureat reflux for 18 h after which it
  2. filtrationwas filtered
  3. concentrationconcentrated to a yellow/orange syrup and crystals (1.4 g)
  4. customPurification by column chromatography on silica gel (200:15—Hexanes:EtOAc)

Quellen und Nachweise

ORD-Eintrag
ord-dab199994697470a9010da92e0d118eb
Quelldatensatz
uspto-grants-2006_08
Patentnummer
US07091217B2

Verknüpfte Notizen

Wird geladen…